Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.34M Buy
44,883
+5,901
+15% +$907K 0.42% 58
2025
Q4
$6.23M Sell
38,982
-10,556
-21% -$1.93M 0.35% 69
2025
Q3
$8.32M Sell
49,538
-322
-0.6% -$39.4K 0.45% 44
2025
Q2
$5.35M Sell
49,860
-3,929
-7% -$300K 0.31% 77
2025
Q1
$4.1M Buy
53,789
+17,693
+49% +$1.35M 0.35% 64
2024
Q4
$2.49M Buy
+36,096
New +$2.6M 0.15% 143

Other funds holding INSM

NWAM LLC's INSM Position: Q1 2026 in Review

NWAM LLC increased its Insmed (INSM) stake by 15% in Q1 2026, buying an estimated $907K and bringing the position to 44,883 shares worth $7.34M. The position accounts for 0.42% of the portfolio, ranked #58.

NWAM LLC first reported a position in INSM in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.32M in Q3 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • NWAM LLC held 44,883 shares of Insmed worth $7.34M as of Q1 2026.
  • NWAM LLC bought 5,901 Insmed shares in Q1 2026, an estimated $907K.
  • Insmed made up 0.42% of NWAM LLC's portfolio in Q1 2026, its #58 holding.
  • NWAM LLC first reported a position in Insmed in Q4 2024 and has held it in 6 quarters since.
  • NWAM LLC's Insmed position peaked at $8.32M in Q3 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.